|Mr. Fredrik Dalborg||CEO & Group Pres||3.67M||N/A||1972|
|Ms. Christina Rubenhag||Sr. VP & CFO||N/A||N/A||N/A|
|Ms. Eva Ekermann||HR Director||N/A||N/A||N/A|
|Ms. Karen Bornstein||Head of Marketing, North & South America||N/A||N/A||N/A|
|Mr. Michael Eliott||Head of Devel. - Reagents & Consumables||N/A||N/A||N/A|
Boule Diagnostics AB (publ), a diagnostics company, develops, manufactures, and markets instruments and consumable products for blood diagnostics. It provides hematology analyzers, reagents, blood controls and calibrators, and reagents rotors, as well as cleaning kits and plastic micro capillaries under the Swelab, Medonic, and Quintus brands; and veterinary clinical chemistry analyzer and diagnostics systems under the Exigo brand. The company sells its products directly in Sweden and the United States, as well as through distributors internationally. It serves hospitals, clinics, laboratories, healthcare centers and veterinary clinics, and companies in blood diagnostics. Boule Diagnostics AB (publ) was founded in 1956 and is headquartered in Spånga, Sweden.
Boule Diagnostics AB (publ)’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.